AlphaYouCCCC insider receives 4,618 shares in stock awards
By AlphaYouPublished Form 4
GROGAN DONNA ROY
Reporting filer
GROGAN DONNA ROY reported 4,618 shares of Common Stock in C4 Therapeutics, Inc. as grants or awards dated 2026-10-01. The Form 4 was disclosed on Oct 2, 2026. These were stock awards, not open-market purchases.
- Disclosed
- Oct 2, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | GROGAN DONNA ROY | 2026-10-01 | A | Grant or award | 4618 | 3.14 | 79,471 | 1 day | Filed terms
|
Common Stock
- Owner
- GROGAN DONNA ROY
- Date
- 2026-10-01
- Code
- A
- Action
- Grant or award
- Quantity
- 4618
- Price
- 3.14
- Following holdings
- 79,471
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-01
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- id: F1
- transaction Shares: 4618
- transaction Price Per Share: 3.14
- id: F2
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 79471
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- GROGAN DONNA ROY: Director.
- F1: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.
- F2: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 1, 2026.
Original sources
Prepared automatically from public filing data. Report a correction.